Gumikas, Samia .

HRN: 22-22-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
AMPICILLIN 1GM (VIAL)
02/14/2023
02/21/2023
IV
2 Grams
Now
Thicky MSAF
Waiting Final Action 
02/14/2023
AMPICILLIN 1GM (VIAL)
02/14/2023
02/21/2023
IV
1 Gram
Q 6hrs
Thicky MSAF
Waiting Final Action 
02/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/14/2023
02/14/2023
IV
500mg
Now
Thicky MSAF
Waiting Final Action 
02/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/14/2023
02/15/2023
IV
500mg
Q 8hrs X 3 Doses
Thicky MSAF
Waiting Final Action 
02/14/2023
AMPICILLIN 1GM (VIAL)
02/14/2023
02/15/2023
IV
2 Grams
Q6h X 4 Doses
Thickly MSAF
Waiting Final Action 
02/15/2023
CEFUROXIME 500MG (TAB)
02/15/2023
02/21/2023
ORAL
500mg
BID
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: